Elizabeth N. Mutubuki

Apr 5, 2023 | medrxiv.org | Elizabeth N. Mutubuki |Hans Knoop |Siméon De Bruijn |Jaap Slootweg

AbstractBackground: Different SARS-CoV-2 variants can differentially affect the prevalence of Post Covid-19 Condition (PCC). This prospective study assesses prevalence and severity of symptoms three months after an Omicron infection, compared to Delta, test-negative and population controls. This study also assesses symptomology after reinfection and breakthrough infections . Methods: After a positive SARS-CoV-2 test, cases were classified as Omicron or Delta based on ≥ 85% surveillance prevalence.